Investigational Site Number 840103 — Mount Vernon, Washington

Investigational Site Number 840103 is a clinical research site located in Mount Vernon, Washington, United States 98273.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840103 has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer Recurrent.

Sponsors: Esperance Pharmaceuticals Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840103?

Investigational Site Number 840103 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840103 conducted?

Investigational Site Number 840103 has 1 clinical trials on record. Their work covers Ovarian Cancer Recurrent.

Is Investigational Site Number 840103 accredited by Crixeo Health?

Investigational Site Number 840103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.